SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882104-20-000211
Filing Date
2020-12-17
Accepted
2020-12-17 16:49:14
Documents
1
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160824173910716.html 4  
1 FORM 4 wf-form4_160824173910716.xml 4 3113
  Complete submission text file 0000882104-20-000211.txt   4568
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
Stone Christopher Lewis (Reporting) CIK: 0001453373 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 201396669